ALTERITY THERAPEUTICS LTD

ASX: ATH (ALTERITY FPO [ATH])

Last update: 10 May, 3:57AM

0.008

0.00 (14.29%)

Previous Close 0.007
Open 0.008
Volume 36,927,722
Avg. Volume (3M) 30,542,295
Market Cap 51,292,004
Price / Sales 735.64
Price / Book 13.69
52 Weeks Range
0.002 (-75%) — 0.019 (137%)
Earnings Date 28 Feb 2025
Operating Margin (TTM) -469.68%
Diluted EPS (TTM) 0.000
Quarterly Revenue Growth (YOY) -15.50%
Total Debt/Equity (MRQ) 1.36%
Current Ratio (MRQ) 3.84
Operating Cash Flow (TTM) -16.47 M
Levered Free Cash Flow (TTM) -8.87 M
Return on Assets (TTM) -78.37%
Return on Equity (TTM) -155.77%

Market Trend

Short Term Medium Term
Industry Biotechnology (AU) Mixed Mixed
Biotechnology (Global) Mixed Bearish
Stock ALTERITY FPO [ATH] - -

AIStockmoo Score

1.1
Analyst Consensus 0.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 2.5
Technical Oscillators 4.0
Average 1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ATH 51 M - - 13.69
ATX 114 M - - 5.27
RCE 88 M - - 208.12
RAD 56 M - - 0.970
TYP 45 M - - 10.53
CYP 35 M - - 3.15

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 6.10%
% Held by Institutions 13.83%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria